205 related articles for article (PubMed ID: 18336307)
1. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets.
Nishimori I; Onishi S; Takeuchi H; Supuran CT
Curr Pharm Des; 2008; 14(7):622-30. PubMed ID: 18336307
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Minakuchi T; Kohsaki T; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 Jul; 17(13):3585-94. PubMed ID: 17482815
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
Nishimori I; Vullo D; Minakuchi T; Morimoto K; Onishi S; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Apr; 16(8):2182-8. PubMed ID: 16459077
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
Nishimori I; Minakuchi T; Morimoto K; Sano S; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2006 Mar; 49(6):2117-26. PubMed ID: 16539401
[TBL] [Abstract][Full Text] [Related]
5. The periplasmic alpha-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation.
Marcus EA; Moshfegh AP; Sachs G; Scott DR
J Bacteriol; 2005 Jan; 187(2):729-38. PubMed ID: 15629943
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis for the Inhibition of Helicobacter pylori α-Carbonic Anhydrase by Sulfonamides.
Modak JK; Liu YC; Machuca MA; Supuran CT; Roujeinikova A
PLoS One; 2015; 10(5):e0127149. PubMed ID: 26010545
[TBL] [Abstract][Full Text] [Related]
7. The alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 is highly susceptible to inhibition by sulfonamides.
Vullo D; Luca VD; Scozzafava A; Carginale V; Rossi M; Supuran CT; Capasso C
Bioorg Med Chem; 2013 Mar; 21(6):1534-8. PubMed ID: 22883029
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of alpha- and beta-carbonic anhydrase in Helicobacter pylori.
Chirica LC; Petersson C; Hurtig M; Jonsson BH; Borén T; Lindskog S
Biochim Biophys Acta; 2002 Dec; 1601(2):192-9. PubMed ID: 12445482
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the alpha- and beta-carbonic anhydrases from the gastric pathogen Helycobacter pylori with anions.
Maresca A; Vullo D; Scozzafava A; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):388-91. PubMed ID: 22299578
[TBL] [Abstract][Full Text] [Related]
10. Roles of alpha and beta carbonic anhydrases of Helicobacter pylori in the urease-dependent response to acidity and in colonization of the murine gastric mucosa.
Bury-Moné S; Mendz GL; Ball GE; Thibonnier M; Stingl K; Ecobichon C; Avé P; Huerre M; Labigne A; Thiberge JM; De Reuse H
Infect Immun; 2008 Feb; 76(2):497-509. PubMed ID: 18025096
[TBL] [Abstract][Full Text] [Related]
11. Cloning, polymorphism, and inhibition of beta-carbonic anhydrase of Helicobacter pylori.
Morishita S; Nishimori I; Minakuchi T; Onishi S; Takeuchi H; Sugiura T; Vullo D; Scozzafava A; Supuran CT
J Gastroenterol; 2008; 43(11):849-57. PubMed ID: 19012038
[TBL] [Abstract][Full Text] [Related]
12. Cloning, purification and preliminary crystallographic analysis of the complex of Helicobacter pylori α-carbonic anhydrase with acetazolamide.
Modak JK; Revitt-Mills SA; Roujeinikova A
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Nov; 69(Pt 11):1252-5. PubMed ID: 24192362
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the Helicobacter pylori carbonic anhydrases.
Stähler FN; Ganter L; Lederer K; Kist M; Bereswill S
FEMS Immunol Med Microbiol; 2005 May; 44(2):183-9. PubMed ID: 15866214
[TBL] [Abstract][Full Text] [Related]
14. Heterocyclic compounds as carbonic anhydrase inhibitor.
Husain A; Madhesia D
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):773-83. PubMed ID: 21981003
[TBL] [Abstract][Full Text] [Related]
15. Structure-Activity Relationship for Sulfonamide Inhibition of Helicobacter pylori α-Carbonic Anhydrase.
Modak JK; Liu YC; Supuran CT; Roujeinikova A
J Med Chem; 2016 Dec; 59(24):11098-11109. PubMed ID: 28002963
[TBL] [Abstract][Full Text] [Related]
16. Novel carbonic anhydrase inhibitors for the treatment of
Supuran CT
Expert Opin Investig Drugs; 2024 May; 33(5):523-532. PubMed ID: 38517734
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrases as targets for medicinal chemistry.
Supuran CT; Scozzafava A
Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
[TBL] [Abstract][Full Text] [Related]
18. Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
Nishimori I; Vullo D; Minakuchi T; Scozzafava A; Capasso C; Supuran CT
Bioorg Med Chem; 2014 Jun; 22(11):2939-46. PubMed ID: 24792813
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrases--an overview.
Supuran CT
Curr Pharm Des; 2008; 14(7):603-14. PubMed ID: 18336305
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrases as drug targets--an overview.
Supuran CT
Curr Top Med Chem; 2007; 7(9):825-33. PubMed ID: 17504127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
